Lipid-based nanoformulations for peptide delivery

Abstract :

Nanoformulations have attracted a lot of attention because of their size-dependent properties. Among the array of nanoformulations, lipid nanoformulations (LNFs) have evoked increasing interest because of the advantages of their high degree of biocompatibility and versatility. The performance of lipid nanoformulations is greatly influenced by their composition and structure. Therapeutic peptides represent a growing share of the pharmaceutical market. However, the main challenge for their development into commercial products is their inherent physicochemical and biological instability. Important peptides such as insulin, calcitonin and cyclosporin A have been incorporated into LNFs. The association or encapsulation of peptides within lipid-based carriers has shown to protect the labile molecules against enzymatic degradation. This review describes strategies used for the formulation of peptides and some methods used for the assessment of association efficiency. The advantages and drawbacks of such carriers are also described.

Document type :
Journal articles
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-01392463
Contributor : Okina Université d'Angers <>
Submitted on : Friday, November 4, 2016 - 1:52:36 PM
Last modification on : Wednesday, July 17, 2019 - 12:48:02 PM

Identifiers

Collections

Citation

Nada Matougui, Lukas Boge, Anne-Claire Groo, Anita Umerska, Lovisa Ringstad, et al.. Lipid-based nanoformulations for peptide delivery. International Journal of Pharmaceutics, Elsevier, 2016, 502, pp.80-97. ⟨10.1016/j.ijpharm.2016.02.019⟩. ⟨hal-01392463⟩

Share

Metrics

Record views

332